BrainsWay Ltd. reiterated earnings guidance for the year 2023. As a reminder, the company continue to expect to demonstrate revenue growth over 2022 and are targeting breakeven operating income.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,037 ILa | -2.81% | -4.60% | -9.75% |
09/05 | Oppenheimer Adjusts Brainsway Price Target to $11 From $10, Maintains Outperform Rating | MT |
09/05 | HC Wainwright Adjusts Price Target on Brainsway to $15 From $13, Keeps Buy Rating | MT |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.75% | 92.58M | |
+11.73% | 226B | |
+9.53% | 188B | |
+14.63% | 137B | |
+27.47% | 108B | |
+0.57% | 63.19B | |
+13.73% | 52.26B | |
+4.86% | 51B | |
+7.72% | 43.89B | |
+7.86% | 38.07B |
- Stock Market
- Equities
- BWAY Stock
- News BrainsWay Ltd.
- BrainsWay Ltd. Reiterates Earnings Guidance for the Year 2023